Literature DB >> 18513346

Influence of disease features on adherence to prophylactic migraine medication.

M Linde1, P Jonsson, T Hedenrud.   

Abstract

OBJECTIVES: Randomized controlled trials of prophylactic treatments for migraine focus on the effects in an ideal situation and underestimate the impact of non-adherence, which in this study was examined in a natural setting.
MATERIALS AND METHODS: A sample of 174 adult migraineurs with a current prescription of pharmacological prophylaxis were consecutively recruited at a specialist clinic. Logistic regression analysis was performed to analyse the association between adherence (self-reported with the Medication Adherence Report Scale) and number of years with migraine, frequency of attacks, number of days with migraine per month, attack duration, presence of cardinal features, mean intensity of pain, and recovery between attacks.
RESULTS: One third (35%) were non-adherent. Neither demographic characteristics nor any of the disease specific variables were significantly associated with adherence.
CONCLUSION: Characteristics of the disease per se did not predict non-adherence which was also observed among patients with severe migraine. The full benefit of drugs cannot be realized at currently achieved levels of adherence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513346     DOI: 10.1111/j.1600-0404.2008.01042.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

Review 1.  Treatment adherence in patients with headache: a systematic review.

Authors:  Rachelle R Ramsey; Jamie L Ryan; Andrew D Hershey; Scott W Powers; Brandon S Aylward; Kevin A Hommel
Journal:  Headache       Date:  2014-04-17       Impact factor: 5.887

2.  Identifying the factors underlying discontinuation of triptans.

Authors:  Rebecca E Wells; Shira Y Markowitz; Eric P Baron; Joseph G Hentz; Kavita Kalidas; Paul G Mathew; Rashmi Halker; David W Dodick; Todd J Schwedt
Journal:  Headache       Date:  2013-09-03       Impact factor: 5.887

3.  Prophylactic treatment of migraine by GPs: a qualitative study.

Authors:  Frans Dekker; Arie Knuistingh Neven; Boukje Andriesse; David Kernick; Michel D Ferrari; Willem J J Assendelft
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

4.  Locus of control moderates the relationship between headache pain and depression.

Authors:  Robin L Heath; Matilda Saliba; Oula Mahmassani; Stella C Major; Brigitte A Khoury
Journal:  J Headache Pain       Date:  2008-08-05       Impact factor: 7.277

5.  Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study.

Authors:  Charly Gaul; Christina van Doorn; Nadine Webering; Martha Dlugaj; Zaza Katsarava; Hans-Christoph Diener; Günther Fritsche
Journal:  J Headache Pain       Date:  2011-05-05       Impact factor: 7.277

6.  Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations.

Authors:  Monali Bhosle; Joshua S Benner; Mitch Dekoven; Jeff Shelton
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

Review 7.  The association between migraine and physical exercise.

Authors:  Faisal Mohammad Amin; Stavroula Aristeidou; Carlo Baraldi; Ewa K Czapinska-Ciepiela; Daponte D Ariadni; Davide Di Lenola; Cherilyn Fenech; Konstantinos Kampouris; Giorgos Karagiorgis; Mark Braschinsky; Mattias Linde
Journal:  J Headache Pain       Date:  2018-09-10       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.